PRF 120
Alternative Names: PRF-120Latest Information Update: 10 Oct 2023
At a glance
- Originator PainReform
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Neuropathic pain
Most Recent Events
- 10 Oct 2023 Preclinical trials in Neuropathic pain in Israel (Parenteral) prior to October 2023 (PainReform pipeline, October 2023)